NEONC TECHNOLOGIES HOLDINGS

Neonc (NTHI) sees a modest uptick amid breakthrough intranasal CNS therapy trials, strategic Abu Dhabi partnerships, and a high‑profile Dr. Drew interview. Explore how early clinical success and media exposure could reshape investor sentiment and li…

Neonc shares jump 4.69 % to $2.90, below its 200‑day SMA, as investors eye growth‑oriented tech. Learn key price insights, liquidity, and peer trends.